First Citizens Bank & Trust Co. lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 2.2% during the third quarter, Holdings Channel reports. The firm owned 88,155 shares of the healthcare conglomerate’s stock after selling 2,009 shares during the period. UnitedHealth Group comprises 1.1% of First Citizens Bank & Trust Co.’s portfolio, making the stock its 16th largest position. First Citizens Bank & Trust Co.’s holdings in UnitedHealth Group were worth $12,342,000 as of its most recent filing with the SEC.

Several other large investors have also bought and sold shares of the company. Van Hulzen Asset Management LLC acquired a new stake in UnitedHealth Group during the second quarter valued at about $104,000. Archford Capital Strategies LLC boosted its stake in UnitedHealth Group by 669.2% in the second quarter. Archford Capital Strategies LLC now owns 800 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 696 shares during the period. Adirondack Trust Co. boosted its stake in UnitedHealth Group by 16.4% in the third quarter. Adirondack Trust Co. now owns 885 shares of the healthcare conglomerate’s stock valued at $124,000 after buying an additional 125 shares during the period. Hanson McClain Inc. boosted its stake in UnitedHealth Group by 0.4% in the second quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock valued at $126,000 after buying an additional 4 shares during the period. Finally, Howe & Rusling Inc. boosted its stake in UnitedHealth Group by 4.5% in the second quarter. Howe & Rusling Inc. now owns 920 shares of the healthcare conglomerate’s stock valued at $130,000 after buying an additional 40 shares during the period. Institutional investors and hedge funds own 84.80% of the company’s stock.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Shares of UnitedHealth Group Incorporated (NYSE:UNH) opened at 161.80 on Friday. The company has a market cap of $154.00 billion, a PE ratio of 23.90 and a beta of 0.67. UnitedHealth Group Incorporated has a one year low of $108.83 and a one year high of $164.00. The company’s 50-day moving average price is $160.37 and its 200 day moving average price is $145.70.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 18th. The healthcare conglomerate reported $2.17 EPS for the quarter, beating the Zacks’ consensus estimate of $2.08 by $0.09. The business earned $46.30 billion during the quarter, compared to analyst estimates of $46.09 billion. UnitedHealth Group had a net margin of 3.62% and a return on equity of 19.92%. The firm’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.77 earnings per share. Equities analysts forecast that UnitedHealth Group Incorporated will post $8.02 EPS for the current fiscal year.

WARNING: This article was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The original version of this article can be read at http://www.watchlistnews.com/first-citizens-bank-trust-co-sells-2009-shares-of-unitedhealth-group-incorporated-unh/1061283.html.

Several brokerages recently weighed in on UNH. Mizuho raised UnitedHealth Group from a “neutral” rating to a “buy” rating and set a $178.00 target price on the stock in a research report on Wednesday, November 30th. RBC Capital Markets increased their target price on UnitedHealth Group from $168.00 to $175.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 30th. Cowen and Company set a $175.00 target price on UnitedHealth Group and gave the stock a “buy” rating in a research report on Wednesday, November 30th. Leerink Swann increased their target price on UnitedHealth Group from $185.00 to $195.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 30th. Finally, Jefferies Group increased their target price on UnitedHealth Group from $168.00 to $182.00 and gave the stock a “buy” rating in a research report on Wednesday, November 30th. Twenty-two equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $165.62.

In other news, Director Kenneth Irwin Shine sold 325 shares of the company’s stock in a transaction dated Friday, October 21st. The shares were sold at an average price of $144.99, for a total transaction of $47,121.75. Following the completion of the transaction, the director now owns 28,613 shares of the company’s stock, valued at $4,148,598.87. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Richard T. Burke sold 15,000 shares of the company’s stock in a transaction dated Thursday, December 15th. The shares were sold at an average price of $159.80, for a total transaction of $2,397,000.00. Following the transaction, the director now directly owns 1,940,030 shares of the company’s stock, valued at approximately $310,016,794. The disclosure for this sale can be found here. Insiders own 1.65% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.